ACSVL1 activators represent a distinct group of compounds that engage the enzymatic activity of Acyl-CoA Synthetase Very-Long-Chain Family Member 1 (ACSVL1), also known as Fatty Acid Transport Protein 5 (FATP5). ACSVL1 is an enzyme that plays a pivotal role in lipid metabolism by catalyzing the conversion of free long-chain fatty acids into fatty acyl-CoA esters, thereby facilitating their subsequent utilization or storage within the cell. The protein is integral to the process of fatty acid activation, a biochemical step essential for the breakdown or synthesis of lipids.
Activators of ACSVL1 may operate through direct interaction with the enzyme, leading to an increase in its catalytic efficiency. Such compounds could bind to allosteric sites on the enzyme, triggering a conformational alteration that enhances its affinity for fatty acid substrates or its ability to convert these substrates into their activated CoA forms. The activation may also involve the stabilization of the ACSVL1 protein structure in a state that is more conducive to the execution of its enzymatic function. Indirect activators, conversely, might not bind to ACSVL1 directly but can augment its activity by modulating the expression levels of the protein, influencing the transcriptional or translational mechanisms that govern its synthesis. Alternatively, they might impact the post-translational modifications that affect the enzyme's stability and function, such as phosphorylation or ubiquitination. The cellular abundance of fatty acids, which are substrates for ACSVL1, can also be indirectly manipulated by activators that affect the uptake or release of fatty acids by the cell, thereby indirectly modulating ACSVL1 activity by increasing substrate availability.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $286.00 $806.00 $1510.00 | 1 | |
Metformin activates AMP-activated protein kinase (AMPK), which can enhance fatty acid oxidation. As ACSVL1 plays a role in these processes, metformin can enhance the functional activity of ACSVL1. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
Fenofibrate is a PPARα agonist that upregulates genes involved in fatty acid metabolism. ACSVL1 is among these genes, so fenofibrate can enhance the functional activity of ACSVL1. |